Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) — Net Asset Momentum
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) recorded a net asset momentum of 16.8% as of December 2025, with net assets of CN¥1.96 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See operational self-sufficiency of Shandong Bailong Chuangyuan Bio-Tech Co. to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. Net Asset Momentum (2016–2025)
This chart tracks Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s year-over-year net asset growth across 10 annual reporting periods from 2016 to 2025. The most recent momentum reading is +16.8%, with net assets of CN¥1.96 Billion CNY as of December 2025. Read 605016 current and long-term liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (2016–2025)
The table below shows the complete annual net asset history for Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. from 2016 to 2025, covering 10 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see 605016 stock market capitalisation.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥1.96 Billion | CN¥2.44 Billion | CN¥475.19 Million | ▲ +16.8% |
| 2024 | CN¥1.68 Billion | CN¥2.01 Billion | CN¥334.27 Million | ▲ +11.4% |
| 2023 | CN¥1.51 Billion | CN¥1.75 Billion | CN¥246.35 Million | ▲ +12.1% |
| 2022 | CN¥1.34 Billion | CN¥1.47 Billion | CN¥126.99 Million | ▲ +11.8% |
| 2021 | CN¥1.20 Billion | CN¥1.28 Billion | CN¥79.05 Million | ▲ +74.1% |
| 2020 | CN¥691.09 Million | CN¥836.00 Million | CN¥144.91 Million | ▲ +15.7% |
| 2019 | CN¥597.07 Million | CN¥754.35 Million | CN¥157.28 Million | ▲ +19.0% |
| 2018 | CN¥501.71 Million | CN¥609.80 Million | CN¥108.09 Million | ▲ +15.0% |
| 2017 | CN¥436.41 Million | CN¥625.78 Million | CN¥189.38 Million | ▲ +20.3% |
| 2016 | CN¥362.67 Million | CN¥631.82 Million | CN¥269.14 Million | — |